Literature DB >> 26163555

Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease.

Irene Russo1, Anna Ferrazzi1, Irene Zanetti1, Mauro Alaibac1.   

Abstract

Epidermolysis bullosa acquisita is a rare, acquired, autoimmune subepidermal blistering disease of the skin, characterised by blisters and erosions, especially in trauma-prone sites and extensor skin surface, scarring with formation of milia, skin fragility and nail dystrophy. Epidermolysis bullosa acquisita is extremely rare in childhood and it has been reported to be frequently associated with Crohn's disease. Furthermore, autoantibodies against type VII collagen have been found in a large number of patients with Crohn's disease without epidermolysis bullosa acquisita. We report a case of a 17-year-old boy affected by Crohn's disease who presented with milia on infiltrated erythematous plaques over the back of the hands. The diagnosis of epidermolysis bullosa acquisita was confirmed by histopathology, direct and indirect immunofluorescence analysis and ELISA. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26163555      PMCID: PMC4499763          DOI: 10.1136/bcr-2015-210210

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone.

Authors:  E Schmidt; S Reimer; N Kruse; E B Bröcker; D Zillikens
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 2.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

3.  Childhood epidermolysis bullosa acquisita: report of a Chinese case.

Authors:  Baoqi Yang; Chong Wang; Na Wang; Futang Pan; Shengli Chen; Guizhi Zhou; Meiling Yu; Furen Zhang
Journal:  Pediatr Dermatol       Date:  2011-10-04       Impact factor: 1.588

Review 4.  Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature.

Authors:  C J Arpey; B E Elewski; D K Moritz; W R Gammon
Journal:  J Am Acad Dermatol       Date:  1991-05       Impact factor: 11.527

Review 5.  Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature.

Authors:  H Reddy; A R Shipman; F Wojnarowska
Journal:  Clin Exp Dermatol       Date:  2013-04       Impact factor: 3.470

Review 6.  Epidermolysis bullosa acquisita. Report of three cases and review of all published cases.

Authors:  H H Roenigk; J G Ryan; W F Bergfeld
Journal:  Arch Dermatol       Date:  1971-01

Review 7.  Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.

Authors:  G Kirtschig; D Murrell; F Wojnarowska; N Khumalo
Journal:  Cochrane Database Syst Rev       Date:  2003

8.  Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses.

Authors:  V Thuong-Nguyen; D P Kadunce; J D Hendrix; W R Gammon; J J Zone
Journal:  J Invest Dermatol       Date:  1993-04       Impact factor: 8.551

9.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

Review 10.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

View more
  1 in total

1.  Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.

Authors:  Smaranda Diaconescu; Silvia Strat; Gheorghe G Balan; Carmen Anton; Gabriela Stefanescu; Ileana Ioniuc; Ana Maria Alexandra Stanescu
Journal:  Medicina (Kaunas)       Date:  2020-08-23       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.